|
|
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities |
| 1K99DA056288-01 |
|
NIDA |
2022 |
|
|
Neurocognitive implications of cannabidiol (CBD) while aging with HIV |
| 1R03DA057146-01 |
|
NIDA |
2022 |
|
|
Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder |
| 1UG3DA054746-01A1 |
|
NIDA |
2022 |
|
|
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse |
| 2R01DA041931-07A1 |
|
NIDA |
2022 |
|
|
Neural circuitry mediating behavioral flexibility |
| 3R00DA042934-05S2 |
|
NIDA |
2022 |
|
|
Leveraging ΔFosB as a potential therapeutic for Alzheimers Disease |
| 3R01DA040621-07S1 |
|
NIDA |
2022 |
|
|
Methamphetamine Effects on Prefrontal Cortical PV+ Interneurons and Resulting Cognitive Deficits |
| 3R01DA054589-02S1 |
|
NIDA |
2022 |
|
|
Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers |
| 3R43DA053121-01A1S1 |
|
NIDA |
2022 |
|
|
Role of ARX mutations in marmoset brain organoids |
| 3U01DA054170-02S1 |
|
NIDA |
2022 |
|
|
Neuroepigenetic mechanisms of chronic low back pain using histone deacetylases PET imaging |
| 4R33DA048485-03 |
|
NIDA |
2022 |
